http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2003000743-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_417f264c5a18fdd3c5161e77653d1d3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c5110cecad606a084229d73195387c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b1cedc0ad4449279c9e4b57033ab58f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d903912f0c41cabe7c509202dd5b353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16c035558811d00640d1bc0261315c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea9f9fb29934b8c73509033bdcc88fea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027675424727215dc5c3d1cf5a867c23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6855fad00f9269e0e7383b284190c0f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdbb1bf870bf0017607390375b69a4ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad43b6c5ae11b93fbe0f04948f7e579e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7783b828feee8d46eeae9bad45b3f367
publicationDate 2003-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2003000743-A
titleOfInvention NEW DERIVATIVES OF PIRAZOLPIRIDINA REPLACED WITH PIRIDINA REF. READ 34888-SV
abstract THIS INVENTION REFERS TO NEW DERIVATIVES OF PIRAZOLPIRIDINE OF FORMULA I, IN WHICH R1 REPRESENTS 4-PIRIDINYL OR 3-PIRIDINYL; R2 REPRESENTS H, HN2 OR HALOGEN; AS WELL AS SALTS, ISOMEROS AND HYDRAPHS OF THE SAME AS STIMULATORS OF THE SOLUBLE CYCLASE GUANILATE AND FOR THE USE AS AN AGENT FOR THE TREATMENT OF CORONARY-CIRCULATORY DISEASES, HYPERTONIA, THROMBROBEMICAL DISEASES OR DISEASE ASFORMATION OF THE CENTRAL NERVOUS SYSTEM
priorityDate 2000-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992

Total number of triples: 29.